日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells

化疗耐药高危神经母细胞瘤持续细胞的鉴定和表征

Liron D Grossmann,Chia-Hui Chen,Yasin Uzun,Anusha Thadi,Adam J Wolpaw,Kevin Louault,Yael Goldstein,Lea F Surrey,Daniel Martinez,Matteo Calafatti,Mark Gerelus,Peng Gao,Lobin Lee,Khushbu Patel,Rebecca S Kaufman,Guy Shani,Alvin Farrel,Sharon Moshitch-Moshkovitz,Paris Grimaldi,Matthew Shapiro,Nathan M Kendsersky,Jarrett M Lindsay,Colleen E Casey,Kateryna Krytska,Laura Scolaro,Matthew Tsang,David Groff,Smita Matkar,Josh R Kalna,Emily Mycek,Jayne McDevitt,Erin Runbeck,Tasleema Patel,Kathrin M Bernt,Shahab Asgharzadeh,Yves A DeClerck,Yael P Mossé,Kai Tan,John M Maris

Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma

循环肿瘤 DNA 揭示复发/难治性 ALK 驱动神经母细胞瘤患者对劳拉替尼产生耐药性的机制

Esther R Berko #, Gabriela M Witek #, Smita Matkar #, Zaritza O Petrova #, Megan A Wu, Courtney M Smith, Alex Daniels, Joshua Kalna, Annie Kennedy, Ivan Gostuski, Colleen Casey, Kateryna Krytska, Mark Gerelus, Dean Pavlick, Susan Ghazarian, Julie R Park, Araz Marachelian, John M Maris, Kelly C Golds

BRD4 inhibitor IBET upregulates p27kip/cip protein stability in neuroendocrine tumor cells

BRD4 抑制剂 IBET 上调神经内分泌肿瘤细胞中 p27kip/cip 蛋白的稳定性

Lei Wang, Smita Matkar, Gengchen Xie, Chiying An, Xin He, Xiangchen Kong, Xiuheng Liu, Xianxin Hua